LENZ Therapeutics, Inc: Clinical Trials

10 trials sponsored by LENZ Therapeutics, Inc, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed. 4 Phase 2, 4 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4
Phase 34Completed 4
Phase 12Completed 2

Follow LENZ Therapeutics, Inc: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Tolerability and Pharmacokinetics of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Chinese With Presbyopia
LNZ101 (Aceclidine /Brimonidine) ophthalmic solution, LNZ100 (Aceclidine) ophthalmic solution, Placebo (Vehicle) ophthalmic solution - Presbyopia
Phase 1CompletedCorxel Pharmaceuticals212024-03-042024-04-23
Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia
Aceclidine+Brimonidine combination ophthalmic solution, Aceclidine ophthalmic solution, Placebo (Vehicle) ophthalmic solution - Presbyopia, Near Vision
Phase 3CompletedCorxel Pharmaceuticals3002023-09-272025-03-03
Plasma Pharmacokinetics and Safety of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With Presbyopia
Aceclidine + Brimonidine, Aceclidine - Eye Diseases, Presbyopia
Phase 1CompletedLENZ Therapeutics, Inc302023-07-062023-10-16
Phase 3 Efficacy Study of LNZ100 & LNZ101 for the Treatment of Presbyopia
Aceclidine+Brimonidine combination ophthalmic solution, Aceclidine ophthalmic solution, Vehicle - Presbyopia, Near Vision
Phase 3CompletedLENZ Therapeutics, Inc2292023-03-062026-10-08
Phase 3 Safety Study of LNZ100 and LNZ101 for the Treatment of Presbyopia Subjects
Aceclidine+Brimonidine combination ophthalmic solution, Aceclidine ophthalmic solution, Vehicle - Presbyopia, Near Vision
Phase 3CompletedLENZ Therapeutics, Inc3622023-02-212026-05-13
Phase 3 Evaluation of the Safety and Efficacy of LNZ100 & LNZ101 for the Treatment of Presbyopia
Aceclidine+Brimonidine combination ophthalmic solution, Aceclidine ophthalmic solution, Brimonidine - Presbyopia, Refractive Error
Phase 3CompletedLENZ Therapeutics, Inc4692022-12-192026-05-13
Evaluation of the Safety and Effectiveness of Aceclidine (LNZ101) and Aceclidine + Brimonidine (LNZ100) in the Treatment of Presbyopia
Aceclidine+Brimonidine combination ophthalmic solution, Aceclidine ophthalmic solution, Vehicle proprietary ophthalmic solution - Presbyopia, Refractive Errors
Phase 2CompletedLENZ Therapeutics, Inc592022-08-062024-09-05
Evaluation of the Safety and Effectiveness of Aceclidine/Brimonidine (LNZ101) and Aceclidine (LNZ100) in the Treatment of Presbyopia
Aceclidine+Brimonidine combination ophthalmic solution, Aceclidine ophthalmic solution, Vehicle Proprietary Ophthalmic Solution - Presbyopia, Refractive Errors
Phase 2CompletedLENZ Therapeutics, Inc682022-05-052024-09-05
A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia
Aceclidine+tropicamide combination, Aceclidine, Vehicle - Presbyopia
Phase 2CompletedLENZ Therapeutics, Inc582017-04-302022-09-22
Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia
PRX-100, Placebo - Presbyopia
Phase 2CompletedLENZ Therapeutics, Inc202015-09-012017-10-23

Conditions studied

Presbyopia (10)  ·  Eye Diseases (7)  ·  Myopia (6)  ·  Refractive Errors (6)  ·  Miosis (1)

Interventions

Brimonidine Tartrate (5)  ·  aceclidine (5)  ·  Ophthalmic Solutions (2)

Countries

United States (8)  ·  China (2)

Top investigators

Kris Gambelin, BS (3)  ·  Alisyn Facemire, BA (2)  ·  Gail Torkildsen, MD (1)  ·  Gloria Sun (1)  ·  Kris Gameblin (1)  ·  Larry Li, Doctor (1)